Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:4053016rdf:typepubmed:Citationlld:pubmed
pubmed-article:4053016lifeskim:mentionsumls-concept:C0020792lld:lifeskim
pubmed-article:4053016lifeskim:mentionsumls-concept:C1882726lld:lifeskim
pubmed-article:4053016lifeskim:mentionsumls-concept:C0870883lld:lifeskim
pubmed-article:4053016lifeskim:mentionsumls-concept:C0443764lld:lifeskim
pubmed-article:4053016lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:4053016lifeskim:mentionsumls-concept:C0205431lld:lifeskim
pubmed-article:4053016lifeskim:mentionsumls-concept:C0063458lld:lifeskim
pubmed-article:4053016pubmed:issue11 Pt 1lld:pubmed
pubmed-article:4053016pubmed:dateCreated1985-12-2lld:pubmed
pubmed-article:4053016pubmed:abstractTextIndeno[1,2,3-cd]pyrene (IP) is a major environmental pollutant which is carcinogenic on mouse skin and in rat lung. Unlike benzo(a)pyrene, IP is a nonalternant polycyclic aromatic hydrocarbon which is devoid of a bay region. IP was mutagenic in Salmonella typhimurium TA100 in the presence of a 9000 X g supernatant from the livers of Aroclor-pretreated rats. Using a similar activation system, the major metabolites of IP were isolated and identified by comparison with synthetic reference standards. trans-1,2-Dihydro-1,2-dihydroxy-IP, 8-, 9-, and 10-hydroxy-IP, 8- and 9-hydroxy-trans-1,2-dihydro-1,2-dihydroxy-IP, and IP-1,2-quinone are among the metabolites formed in vitro. The 1,2-epoxide of indeno[1,2,3-cd]pyrene is a potent direct-acting mutagen. 8- and 9-hydroxy-IP were mutagenic with metabolic activation. 1-,2-, and 6-hydroxy-IP and the trans-1,2-dihydrodiol had no significant mutagenic activity in S. typhimurium TA100 with metabolic activation. These data suggest that the K-region oxides of IP and of 8- and 9-hydroxy-IP are ultimately responsible for its mutagenic activity.lld:pubmed
pubmed-article:4053016pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:4053016pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:4053016pubmed:languageenglld:pubmed
pubmed-article:4053016pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:4053016pubmed:citationSubsetIMlld:pubmed
pubmed-article:4053016pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:4053016pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:4053016pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:4053016pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:4053016pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:4053016pubmed:statusMEDLINElld:pubmed
pubmed-article:4053016pubmed:monthNovlld:pubmed
pubmed-article:4053016pubmed:issn0008-5472lld:pubmed
pubmed-article:4053016pubmed:authorpubmed-author:LaVoieE JEJlld:pubmed
pubmed-article:4053016pubmed:authorpubmed-author:RiceJ EJElld:pubmed
pubmed-article:4053016pubmed:authorpubmed-author:ColemanD TDTlld:pubmed
pubmed-article:4053016pubmed:authorpubmed-author:HostedT JTJJrlld:pubmed
pubmed-article:4053016pubmed:authorpubmed-author:WileyJ CJCJrlld:pubmed
pubmed-article:4053016pubmed:authorpubmed-author:McCaustlandD...lld:pubmed
pubmed-article:4053016pubmed:issnTypePrintlld:pubmed
pubmed-article:4053016pubmed:volume45lld:pubmed
pubmed-article:4053016pubmed:ownerNLMlld:pubmed
pubmed-article:4053016pubmed:authorsCompleteYlld:pubmed
pubmed-article:4053016pubmed:pagination5421-5lld:pubmed
pubmed-article:4053016pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:4053016pubmed:meshHeadingpubmed-meshheading:4053016-...lld:pubmed
pubmed-article:4053016pubmed:meshHeadingpubmed-meshheading:4053016-...lld:pubmed
pubmed-article:4053016pubmed:meshHeadingpubmed-meshheading:4053016-...lld:pubmed
pubmed-article:4053016pubmed:meshHeadingpubmed-meshheading:4053016-...lld:pubmed
pubmed-article:4053016pubmed:meshHeadingpubmed-meshheading:4053016-...lld:pubmed
pubmed-article:4053016pubmed:meshHeadingpubmed-meshheading:4053016-...lld:pubmed
pubmed-article:4053016pubmed:meshHeadingpubmed-meshheading:4053016-...lld:pubmed
pubmed-article:4053016pubmed:meshHeadingpubmed-meshheading:4053016-...lld:pubmed
pubmed-article:4053016pubmed:meshHeadingpubmed-meshheading:4053016-...lld:pubmed
pubmed-article:4053016pubmed:meshHeadingpubmed-meshheading:4053016-...lld:pubmed
pubmed-article:4053016pubmed:year1985lld:pubmed
pubmed-article:4053016pubmed:articleTitleIdentification of mutagenic metabolites of indeno[1,2,3-cd]pyrene formed in vitro with rat liver enzymes.lld:pubmed
pubmed-article:4053016pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:4053016pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:4053016pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed